OPKO Health

About:

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

Website: http://www.opko.com

Twitter/X: search

Top Investors: HealthCare Royalty Partners

Description:

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies. The company intends to leverage its global commercialization expertise to pursue acquisitions of commercial businesses that will both drive growth and provide geographically diverse sales and distribution opportunities. OPKO has and may continue to make investments in other early stage companies that the company perceives to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder.

Total Funding Amount:

$686M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Miami, Florida, United States

Founded Date:

2005-01-01

Contact Email:

contact(AT)opko.com

Founders:

Phillip Frost

Number of Employees:

501-1000

Last Funding Date:

2024-07-17

IPO Status:

Public

© 2025 bioDAO.ai